Chapter 360-38 PRESCRIPTION DRUG MONITORING PROGRAM
| (1) |
'Board' means the Georgia
Composite Medical Board. |
| (2) |
'PDMP' means the Georgia
Prescription Drug Monitoring Program database. |
| (3) |
'Physician' means an individual
licensed to practice medicine pursuant to Article 2 of Chapter 34 of
Title 43. |
| (4) |
'Prescriber' means an individual who maintains an active DEA
registration to prescribe Schedule Il, Ill, IV or V controlled
substances. |
| (5) |
'Controlled medication' means a medication listed in paragraph (l) or
(2) of Code Section
16-13-26 or
benzodiazepines. |
| (1) |
Prescribers must enroll as a
PDMP user by January 1, 2018. |
| (2) |
Prescribers who obtain a DEA
registration after January 1, 2018 must enroll with the PDMP within
30-days of obtaining a DEA registration for purposes of prescribing
controlled substances in Georgia. |
| (1) |
Access to PDMP information is
granted to following personnel:
| b. |
Not more
than two prescriber's representatives as provided in Code Section
16-13-60,
to monitor the PDMP on his/her behalf. |
|
| (2) |
All information from the PDMP
shall be maintained in a secure and confidential manner. |
| (1) |
On and after July 1, 2018, when
a prescriber is prescribing a controlled medication, he or she shall
seek and review information from the PDMP the first time he or she
issues such prescription to a patient and thereafter at least once
every 90-days, unless:
| a. |
The
prescription is for no more than a three-day supply of a controlled
medication and no more than 26 pills or: |
| b. |
The patient is in a hospital or
health care facility including a nursing and intermediate care home,
a personal care home, or a hospice facility where the medication is
to be administered and used by a patient on the premises of the
facility or: |
| c. |
The
patient has had outpatient surgery at a hospital or ambulatory
surgical center and the prescription is for no more than a ten-day
supply of a controlled medication and no more than 40 pills
or; |
| d. |
The patient is
terminally ill or under the supervised care of an outpatient hospice
program, or; |
| e. |
The
patient is receiving treatment for cancer. |
|
| (2) |
Prescribers or his/her
representatives must make a notation in the patient's medical record
that the PDMP was consulted and identify the individual who conducted
the PDMP search. If the PDMP does not allow access, the prescriber or
his/her representatives shall document that access was not permitted
and note on the medical record the date, time and name of individual
querying the PDMP. |
Failure to comply with the rules and regulations of
the Board is grounds for disciplinary action by the Board under
O.C.G.A. Section
43-34-8.
A prescriber licensed by the Board may be subject to disciplinary
action by Board for the failure to maintain the security of PDMP
information obtained by him or her or by his or her
staff.
